User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study-Reference-Cited by-同舟云学术

User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study

Published:2023-02-20 Issue:2 Volume:28 Page:113-118
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Nogueira-Silva Cristina¹²³,Rolhas Ana⁴,Ramilo Irina⁵,Plancha Marta⁶,Pereira da Silva Daniel⁷

Affiliation:

1. Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal

2. ICVS/3B’s—PT Government Associate Laboratory, Braga, Portugal

3. Department of Obstetrics and Gynecology, Hospital de Braga, Braga, Portugal

4. Department of Obstetrics and Gynecology Centro Hospitalar, Universitário de Coimbra, Coimbra, Portugal

5. Serviço de Ginecologia, Hospital Lusíadas, Lisboa, Portugal

6. Maternidade Alfredo da Costa, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal

7. Instituto Médico de Coimbra & Hospital Cuf Coimbra, Coimbra, Portugal

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2023.2174375

Reference25 articles.

1. Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

2. INFARMED. Summary of product characteristics Levosert(r). 2018. INFARMED, the national authority. Available from: https://extranet.infarmed.pt/INFOMED-fo/detalhes-medicamento.xhtml

3. Levonorgestrel-releasing intra-uterine systems as female contraceptives

4. Impact of a new levonorgestrel intrauterine system, Levosert®, on heavy menstrual bleeding: results of a one-year randomised controlled trial

5. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): Data from an international survey